Finn Sawyer Access to Cancer Testing Act

Adds new coverage rules so Medicare, Medicaid, and CHIP pay for specific cancer diagnostic and laboratory tests (including certain genomic/molecular tests), changes related payment and deductible treatment, and sets effective dates with a short state-law exemption window. Directs HHS, with the National Human Genome Research Institute, to run an education and awareness program for clinicians and the public about genomic testing and to promote training in molecular diagnostics for graduate and continuing medical education so mutations are identified at diagnosis and recurrence.